George Syrmalis

I am an M.D and PhD qualified physician, trained in Nuclear Medicine and Radiation Immunology. My career trajectory took a dynamic turn towards entrepreneurship within the Biotech and Med-Tech sectors. Currently, I dedicate my expertise and insights as an early-stage venture capitalist with Bioscience Equity Partners, focusing on seeding and nurturing startups aimed at revolutionizing the field through groundbreaking therapeutics and Med-Tech innovations.

My entrepreneurial journey saw the founding of the iQ Group Global, under which I spearheaded the incubation and growth of notable entities including Oncotex Inc., INBS: NASDAQ, Biosensx Global Inc., Biosensx North America Inc., Life Science Biosensor Diagnostics, and Antisoma. Serving as CEO of the iQX Investment Services' Fund, I played a critical role in overseeing and steering the Group's investment strategies.

Throughout my career, I have successfully facilitated over ten initial public offerings (IPOs) for subsidiary companies across prestigious platforms such as the ASX, NSX, NASDAQ, and various European exchanges.

Marking a significant tenure in my career, I was the founder and served as the CEO and Chairman of The Bionuclear Group Société anonyme from 1995 to 2005, a period during which I laid the groundwork for what would become a lifelong pursuit of innovation and excellence in the biosciences sector.